Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Change in Cash (2018 - 2025)

Historic Change in Cash for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to -$8.9 million.

  • Viemed Healthcare's Change in Cash fell 45011.81% to -$8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$224000.0, marking a year-over-year decrease of 11765.17%. This contributed to the annual value of $4.7 million for FY2024, which is 21536.2% up from last year.
  • Viemed Healthcare's Change in Cash amounted to -$8.9 million in Q3 2025, which was down 45011.81% from $9.9 million recorded in Q2 2025.
  • Viemed Healthcare's Change in Cash's 5-year high stood at $9.9 million during Q2 2025, with a 5-year trough of -$13.3 million in Q2 2023.
  • Over the past 5 years, Viemed Healthcare's median Change in Cash value was $54000.0 (recorded in 2021), while the average stood at -$1.0 million.
  • Per our database at Business Quant, Viemed Healthcare's Change in Cash plummeted by 1366666.67% in 2022 and then soared by 183972.6% in 2024.
  • Over the past 5 years, Viemed Healthcare's Change in Cash (Quarter) stood at $1.5 million in 2021, then crashed by 396.17% to -$4.6 million in 2022, then surged by 160.5% to $2.8 million in 2023, then surged by 124.3% to $6.2 million in 2024, then tumbled by 243.6% to -$8.9 million in 2025.
  • Its Change in Cash stands at -$8.9 million for Q3 2025, versus $9.9 million for Q2 2025 and -$7.4 million for Q1 2025.